Get started
Author

Lucy Knibbs

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
2021 · Rachael A Evans, Hamish J C McAuley, et al. · The Lancet Respiratory Medicine · 672
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
2022 · R A Evans, O C Leavy, et al. · The Lancet Respiratory Medicine · 413
PDF
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
2022 · Paul R Kalra, John G F Cleland, et al. · The Lancet · 402
PDF
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
2022 · Felicity Liew, Shubha Talwar, et al. · EBioMedicine · 121
Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial
2021 · Rustam Al-Shahi Salman, Catriona Keerie, et al. · The Lancet Neurology · 114
PDF
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
2024 · Felicity Liew, Claudia Efstathiou, et al. · Nature Immunology · 107
PDF
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
2023 · Betty Raman, Celeste McCracken, et al. · The Lancet Respiratory Medicine · 57
PDF
Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage
2021 · Rustam Al-Shahi Salman, Martin S. Dennis, et al. · JAMA Neurology · 50
PDF
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial
2024 · John G F Cleland, Philip A Kalra, et al. · European Heart Journal · 42
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
2023 · Callum Jackson, Iain D Stewart, et al. · The Lancet Respiratory Medicine · 35
Accelerated immune ageing is associated with COVID-19 disease severity
2024 · Janet M. Lord, Tonny Veenith, et al. · Immunity & Ageing · 34
PDF
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
2023 · Bang Zheng, Giulia Vivaldi, et al. · The Lancet Regional Health - Europe · 29
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study
2023 · Hamish J.C. McAuley, Rachael A. Evans, et al. · EClinicalMedicine · 24
PDF
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
2023 · Omer Elneima, Hamish J C McAuley, et al. · International Journal of Epidemiology · 23
PDF
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury
2023 · Maxime Taquet, Zuzanna Skorniewska, et al. · Brain Communications · 14
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Long COVID research: an update from the PHOSP-COVID Scientific Summit
2023 · Christopher E Brightling, Rachael A Evans, et al. · The Lancet Respiratory Medicine · 11
PDF
Works count: 32
Citation count: 4,388
H-index: 22
I10-index: 25
Year
Topic
Type